Earnings Feed
Start Free
|S-1/AJun 28, 4:19 PM ET

Lirum Therapeutics, Inc. S-1/A

S-1/A · Lirum Therapeutics, Inc. · Filed Jun 28, 2024

Documents

24 files
  • S-1
    tm2319041-16_s1a.htm

    S-1/A

  • EX-1.1
    tm2319041d16_ex1-1.htm

    EXHIBIT 1.1

  • EX-3.1
    tm2319041d19_ex3-1.htm

    EXHIBIT 3.1

  • EX-4.2
    tm2319041d19_ex4-2.htm

    EXHIBIT 4.2

  • EX-5.1
    tm2319041d19_ex5-1.htm

    EXHIBIT 5.1

  • EX-23.1
    tm2319041d19_ex23-1.htm

    EXHIBIT 23.1

  • EX-FILING
    tm2319041d19_ex-filingfees.htm

    EX-FILING FEES

  • GRAPHIC
    lg_lirum-4clr.jpg

    GRAPHIC

  • GRAPHIC
    fc_precision-4c.jpg

    GRAPHIC

  • GRAPHIC
    fc_program-4c.jpg

    GRAPHIC

  • GRAPHIC
    tb_igf-4c.jpg

    GRAPHIC

  • GRAPHIC
    tb_approach-4c.jpg

    GRAPHIC

  • GRAPHIC
    tb_uniquely-4c.jpg

    GRAPHIC

  • GRAPHIC
    lc_efficacy-4clr.jpg

    GRAPHIC

  • GRAPHIC
    tb_dose-4c.jpg

    GRAPHIC

  • GRAPHIC
    tb_tumortype-4c.jpg

    GRAPHIC

  • GRAPHIC
    tb_cancer-4c.jpg

    GRAPHIC

  • GRAPHIC
    tb_preclinical-4clr.jpg

    GRAPHIC

  • GRAPHIC
    lc_ewing-4clr.jpg

    GRAPHIC

  • GRAPHIC
    fc_condition-4clr.jpg

    GRAPHIC

  • GRAPHIC
    fc_aberrant-4c.jpg

    GRAPHIC

  • GRAPHIC
    tb_historical-4c.jpg

    GRAPHIC

  • GRAPHIC
    tb_lirumapproach-4c.jpg

    GRAPHIC

  • GRAPHIC
    tm2319041d19_ex5-1img001.jpg

    GRAPHIC